Essentials · Evidence reviewed
Who qualifies for prescription weight-loss medication?
When people ask whether they qualify for weight-loss medication, the answer isn't based on weight alone. Researchers in the STEP 1 study enrolled adults using a combination of body mass index (BMI) and health conditions. Actual prescribing decisions also depend on each medicine's current FDA-approved indications and individual safety considerations.
What does BMI measure?
BMI uses height and weight to create a screening number. It does not directly measure body fat, fitness or medical risk. A clinician will interpret BMI together with medical history, other conditions and the reason for treatment.
What did an important trial require?
The STEP 1 semaglutide trial enrolled adults without diabetes who had a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition. These were study entry rules. They are useful context, but clinical trial eligibility and an individual drug's current FDA labeling are not necessarily identical.
Does meeting a BMI threshold guarantee a prescription?
No. A prescriber must consider contraindications, medical history, other treatments, pregnancy considerations and whether the medicine is suitable for a person's goals. Different products and indications have different eligibility rules.
Will insurance cover it if I'm eligible?
Medical eligibility and insurance eligibility are separate questions. A doctor may determine treatment is appropriate while a plan still excludes weight-management medicine or requires authorization. Verify the exact benefit before assuming coverage.
What should I prepare for an appointment?
Bring a list of current medicines and relevant health conditions, earlier treatments, goals and questions about costs. Your prescriber can explain which options are approved for your situation and what monitoring is needed.
The bottom line
BMI is a starting point, not an automatic prescription or insurance approval.
Written and published by MyDosePro as an educational explanation of publicly available evidence. The linked primary source is dated 2021-02-10. We identify trial registrations separately from published results and do not provide individual prescribing advice.
Primary sourceThis guide explains published evidence; source dates may be older than the review date. Our interpretation is educational and does not replace medical or insurance advice.